{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:31:32Z","timestamp":1770478292784,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.ijrobp.2004.07.710","type":"journal-article","created":{"date-parts":[[2005,3,8]],"date-time":"2005-03-08T18:31:07Z","timestamp":1110306667000},"page":"1087-1095","source":"Crossref","is-referenced-by-count":66,"title":["Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer"],"prefix":"10.1016","volume":"61","author":[{"given":"Robert G.","family":"Prosnitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine L.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Clough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Brizel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2004.07.710_bib1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/0360-3016(89)90523-3","article-title":"The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: Based on RTOG trial #79-15","volume":"17","author":"Fazekas","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib2","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1056\/NEJM199806183382503","article-title":"Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer","volume":"338","author":"Brizel","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib3","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1200\/JCO.1995.13.8.2077","article-title":"Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx","volume":"13","author":"Fein","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib4","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0360-3016(97)00308-8","article-title":"Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx","volume":"38","author":"Tarnawski","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0167-8140(92)80126-4","article-title":"The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma","volume":"23","author":"van Acht","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0360-3016(98)00062-5","article-title":"T1\/T2 glottic cancer managed by external beam radiotherapy: The influence of pretreatment hemoglobin on local control","volume":"41","author":"Warde","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib7","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/jnci\/91.24.2081","article-title":"Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma","volume":"91","author":"Calais","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jnci\/88.9.583","article-title":"Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck","volume":"88","author":"Merlano","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1998.16.4.1318","article-title":"Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study","volume":"16","author":"Wendt","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib10","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib11","first-page":"411a","volume":"19","author":"Adelstein","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-8140(99)00102-4","article-title":"Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome","volume":"53","author":"Brizel","year":"1999","journal-title":"Radiother Oncol"},{"issue":"Suppl. 2","key":"10.1016\/j.ijrobp.2004.07.710_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0360-3016(84)90699-0","article-title":"Blood pressure and hemoglobin concentration: Multivariate analysis of local control after irradiation for head and neck cancer","volume":"10","author":"Blitzer","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0360-3016(98)00348-4","article-title":"Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27","volume":"42","author":"Lee","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s000660050041","article-title":"Anderungen der Hamoglobinkonzentration bei kombinierter Radio- und Chemotherapie lokal fortgeschrittener HNO-Tumoren","volume":"175","author":"Lammering","year":"1999","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma","volume":"22","author":"Denis","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0360-3016(01)01488-2","article-title":"Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx","volume":"50","author":"Glaser","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0360-3016(99)00115-7","article-title":"Influence of the hypoxic subvolume on the survival of patients with head and neck cancer","volume":"44","author":"Stadler","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00066-003-1066-4","article-title":"Tumor volume and tumor hypoxia in head and neck cancers: The amount of the hypoxic volume is important","volume":"179","author":"Dunst","year":"2003","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0360-3016(99)00384-3","article-title":"Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas","volume":"46","author":"Becker","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib21","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0360-3016(84)90312-2","article-title":"Current status and treatment of localized disease and future aspects","volume":"10","author":"Bush","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0167-8140(00)00245-0","article-title":"Anemia, hypoxia and transfusion in patients with cervix cancer: A review","volume":"57","author":"Fyles","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib23","first-page":"583","article-title":"Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study","volume":"88","author":"Benasso","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib24","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1200\/JCO.2001.19.11.2875","article-title":"Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing","volume":"19","author":"Gabrilove","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib25","doi-asserted-by":"crossref","unstructured":"Littlewood TJ, Nortier J, Rapoport B et al. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy. Hematol Oncol 2003;21:169\u2013180.","DOI":"10.1002\/hon.722"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib26","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.2002.08.131","article-title":"Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in hematologic malignancies","volume":"20","author":"Osterborg","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0360-3016(86)90058-1","article-title":"Primary radiotherapy of larynx and pharynx carcinoma\u2014an analysis of some factors influencing local control and survival","volume":"12","author":"Overgaard","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib28","first-page":"226a","article-title":"Multicenter randomized phase II study of 1 hour (H) infusion paclitaxel (T), flourouracil (F) and hydroxyruea (H) with concomitant hyperfractionated radiotherapy (2XRT) with or without erythropoietin (EPO) for advanced head and neck cancer (HNC)","volume":"20","author":"Rosen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib29","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","article-title":"Erythoropoeitin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomized, double-blind, placebo-controlled trial","volume":"362","author":"Henke","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib30","first-page":"741","article-title":"Tumor oxygenation: A matter of supply and demand","volume":"16","author":"Gulledge","year":"1996","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2004.07.710_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogen repopulation during radiotherapy","volume":"27","author":"Withers","year":"1988","journal-title":"Acta Oncologica"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301604021066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301604021066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T03:52:37Z","timestamp":1548647557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301604021066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0360301604021066"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2004.07.710","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}